{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:02:35Z","timestamp":1787868155355,"version":"build-2784847793"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","award":["UIDP \/ 00674 \/2020"],"award-info":[{"award-number":["UIDP \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","award":["UIDB \/ 00674 \/2020"],"award-info":[{"award-number":["UIDB \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","award":["M1420-01-0145"],"award-info":[{"award-number":["M1420-01-0145"]}],"id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","award":["000005"],"award-info":[{"award-number":["000005"]}],"id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["UIDP \/ 00674 \/2020"],"award-info":[{"award-number":["UIDP \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["UIDB \/ 00674 \/2020"],"award-info":[{"award-number":["UIDB \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["M1420-01-0145"],"award-info":[{"award-number":["M1420-01-0145"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["000005"],"award-info":[{"award-number":["000005"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016218","name":"Ag\u00eancia Regional para o Desenvolvimento da Investiga\u00e7\u00e3o, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["UIDP \/ 00674 \/2020"],"award-info":[{"award-number":["UIDP \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/100016218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016218","name":"Ag\u00eancia Regional para o Desenvolvimento da Investiga\u00e7\u00e3o, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["UIDB \/ 00674 \/2020"],"award-info":[{"award-number":["UIDB \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/100016218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016218","name":"Ag\u00eancia Regional para o Desenvolvimento da Investiga\u00e7\u00e3o, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["M1420-01-0145"],"award-info":[{"award-number":["M1420-01-0145"]}],"id":[{"id":"10.13039\/100016218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016218","name":"Ag\u00eancia Regional para o Desenvolvimento da Investiga\u00e7\u00e3o, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["000005"],"award-info":[{"award-number":["000005"]}],"id":[{"id":"10.13039\/100016218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["UIDP \/ 00674 \/2020"],"award-info":[{"award-number":["UIDP \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["UIDB \/ 00674 \/2020"],"award-info":[{"award-number":["UIDB \/ 00674 \/2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["M1420-01-0145"],"award-info":[{"award-number":["M1420-01-0145"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["000005"],"award-info":[{"award-number":["000005"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejmech.2020.112905","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T10:01:47Z","timestamp":1602410507000},"page":"112905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1383-5256","authenticated-orcid":false,"given":"Serge","family":"Mignani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-6645","authenticated-orcid":false,"given":"Xiangyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5760-3086","authenticated-orcid":false,"given":"Andrii","family":"Karpus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Majoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112905_bib1","first-page":"297","article-title":"Tajuddin, trends in nanotechnology for practical applications. Applications of targeted nano drugs and delivery systems","volume":"11","author":"Mohammad","year":"2019","journal-title":"Chapter"},{"key":"10.1016\/j.ejmech.2020.112905_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"C.; robert langer, R., impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2020.112905_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","article-title":"Drug delivery systems: an updated review","volume":"2","author":"Tiwari","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ejmech.2020.112905_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","article-title":"Controlled drug release from pharmaceutical nanocarriers","volume":"125","author":"Lee","year":"2015","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib5","first-page":"25e37","article-title":"Therapeutic nanoparticles: state of the art of the medicine","volume":"1","author":"Athar","year":"2014","journal-title":"Adv. Mater. Rev."},{"key":"10.1016\/j.ejmech.2020.112905_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsps.2011.04.001","article-title":"Nanoparticles: emerging carriers for drug delivery","volume":"19","author":"Mudshinge","year":"2011","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ejmech.2020.112905_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging","volume":"8","author":"Parveen","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejmech.2020.112905_bib8","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1039\/C1CS15242D","article-title":"Multifunctional dendritic polymers in nanomedicine: opportunities and challenges","volume":"41","author":"Khandare","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2020.112905_bib9","doi-asserted-by":"crossref","unstructured":"Kannan, R. M.; Nance, E.; Kannan, S.; Tomalia, D. A., Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J. Intern. Med. 214, 276, 579\u2013617..","DOI":"10.1111\/joim.12280"},{"key":"10.1016\/j.ejmech.2020.112905_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/biom10040642","article-title":"The role of branch cell symmetry and other critical nanoscale design parameters in the determination of dendrimer encapsulation properties","volume":"10","author":"Tomalia","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib11","first-page":"9","article-title":"Dendrimers: synthesis, applications, and properties","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejmech.2020.112905_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ma13010065","article-title":"Dendrimers as pharmaceutical excipients: synthesis, properties, toxicity and biomedical applications","volume":"13","author":"Santos","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.ejmech.2020.112905_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/mp050023q","article-title":"Dendrimers as Drugs:\u2009 discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention","volume":"2","author":"McCarthy","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1039\/C9NR00303G","article-title":"New anionic poly(alkylideneamine) dendrimers as microbicide agents against HIV-1 infection","volume":"11","author":"Maciel","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejmech.2020.112905_bib15","first-page":"9","article-title":"In\u00a0vitro anti-cancer properties of copper metallodendrimers","author":"Holota","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/molecules23061471","article-title":"Poly(alkylidenimine) dendrimers functionalized with the organometallic moiety [Ru(\u03b7\u2075-C\u2085H\u2085)(PPh\u2083)\u2082]\u207a as promising drugs against cisplatin-resistant cancer cells and human mesenchymal stem cells","volume":"23","author":"Gouveia","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib17","first-page":"165","volume":"vol. 63","author":"Chabre","year":"2010"},{"key":"10.1016\/j.ejmech.2020.112905_bib18","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1039\/b507350b","article-title":"Tumor angiogenic vasculature targeting with PAMAM dendrimer\u2013RGD conjugates","author":"Shukla","year":"2005","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112905_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2018.12.012","article-title":"Antimicrobial efficacy and mechanism of action of poly(amidoamine) (PAMAM) dendrimers against opportunistic pathogens","volume":"53","author":"Holmes","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112905_bib20","first-page":"11","article-title":"Metal-based phosphorus dendrimers as novel nanotherapeutic strategies to tackle cancers: a concise overview","author":"Chen","year":"2019","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2020.112905_bib21","article-title":"Revisiting cationic phosphorus dendrimers as a nonviral vector for optimized gene delivery towards cancer therapy applications","author":"Chen","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib22","article-title":"A\u00a0phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis","volume":"81","author":"Hayder","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2020.112905_bib23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2013.01.001","article-title":"Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a Concise overview","volume":"35","author":"Mignani","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2020.112905_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jps.21079","article-title":"Dendrimers as drug carriers: applications in different routes of drug administration","volume":"97","author":"Cheng","year":"2008","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib25","author":"Saikat"},{"key":"10.1016\/j.ejmech.2020.112905_bib27","author":"Merck Manual Professional version"},{"key":"10.1016\/j.ejmech.2020.112905_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/biom9120790","article-title":"Dendrimer-based drug delivery systems for brain targeting","volume":"9","author":"Zhu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib29","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1039\/c3nj00300k","article-title":"Dendrimers as macromolecular tools to tackle from colon to brain tumor types : a concise overview","volume":"37","author":"Mignani","year":"2013","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2020.112905_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/mp300391v","article-title":"In\u00a0vivo distribution and toxicity of PAMAM dendrimers inthe central nervous","volume":"10","author":"Albertazzi","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2014.12.042","article-title":"In\u00a0vivo delivery of siRNA to the brain by carbosilane dendrimer","volume":"200","author":"Serram\u00eda","year":"2015","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2020.112905_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/17435889.3.5.679","article-title":"Dendrimers for enhanced drug solubilization","volume":"3","author":"Svenson","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejmech.2020.112905_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.12.002","article-title":"Performance evaluation of PAMAM dendrimer based simvastatin formulations","volume":"405","author":"Kulhari","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jddst.2019.04.017","article-title":"Intranasal drug delivery: novel delivery route for effective management of neurological disorders","volume":"52","author":"Patel","year":"2019","journal-title":"J.\u00a0Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2020.112905_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/pharmaceutics11020084","article-title":"Nanoemulsions for \u201cnose-to-brain\u201d drug delivery","volume":"11","author":"Bonferoni","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2020.112905_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/08958370490439597","article-title":"Translocation of inhaled ultrafine particles to the brain","volume":"16","author":"Oberd\u00f6rster","year":"2004","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ejmech.2020.112905_bib37","series-title":"Taste and Smell in Vertebrates","first-page":"151","article-title":"The olfactory neuron and the blood\u2013brain barrier","author":"De Lorenzo","year":"1970"},{"key":"10.1016\/j.ejmech.2020.112905_bib38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1289\/ehp.9030","article-title":"Translocation of inhaled ultra-fine manganese oxide particles to the central nervous system","volume":"114","author":"Elder","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2020.112905_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3171\/jns.2000.92.4.0599","article-title":"In\u00a0vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans","volume":"92","author":"Siegal","year":"2000","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.ejmech.2020.112905_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nurt.2009.01.018","article-title":"Nanotechnology for delivery of drugs to the brain for epilepsy","volume":"6","author":"Bennewitz","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2020.112905_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1020626419269","article-title":"New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery","volume":"60","author":"Carson","year":"2002","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.ejmech.2020.112905_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2014.06.017","article-title":"Agile delivery of protein therapeutics to CNS.","volume":"190","author":"Yi","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2020.112905_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejps.2013.01.007","article-title":"Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in\u00a0vitro and in\u00a0vivo evaluation","volume":"48","author":"Zhang","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"Brain Res. Bull.","key":"10.1016\/j.ejmech.2020.112905_bib44","first-page":"155","volume":"143","author":"Erd\u0151a","year":"2018","journal-title":"Evaluation of intranasal delivery route of drug administration for brain targeting"},{"issue":"Suppl 3","key":"10.1016\/j.ejmech.2020.112905_bib45","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejmech.2020.112905_bib46","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/DDDT.S100075","article-title":"Drug delivery in overcoming the blood\u2013brain barrier: role of nasal mucosal grafting","volume":"11","author":"Marianecci","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2020.112905_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00126839-200708030-00001","article-title":"Can nasal drug delivery bypass the blood-brain barrier?","volume":"8","author":"Merkus","year":"2007","journal-title":"Drugs R"},{"key":"10.1016\/j.ejmech.2020.112905_bib49","first-page":"2088","article-title":"Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting","volume":"46","author":"Selvaraj","year":"2018","journal-title":"Artif. Cell Nanomed. B"},{"key":"10.1016\/j.ejmech.2020.112905_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","article-title":"A\u00a0review of intranasal formulations for the treatment of seizure emergencies","volume":"237","author":"Kapoor","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2020.112905_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowea","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose to brain delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112905_bib53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.toxlet.2014.04.020","article-title":"Effects of PAMAM dendrimers in the mouse brain after a singleintranasal instillation","volume":"228","author":"Win-Shwe","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2020.112905_bib55","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2020.112905_bib56","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.drudis.2018.01.005","article-title":"An update on the role of nanovehicles in nose-to-brain drug delivery","volume":"23","author":"Feng","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112905_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejmech.2020.112905_bib58","first-page":"4440","article-title":"Intranasal administration of CNS therapeutics to awake mice","volume":"74","author":"Hanson","year":"2013","journal-title":"JoVE"},{"key":"10.1016\/j.ejmech.2020.112905_bib59","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/molecules25081929","article-title":"Intranasal delivery of nanoformulations: a potential way of treatment for neurological disorders","volume":"25","author":"Ul Islam","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/pharmaceutics11030118","article-title":"Epilepsy disease and nose-to-brain delivery of polymeric nanoparticles: an overview","volume":"11","author":"Musumeci","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2020.112905_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon- to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2020.112905_bib62","first-page":"610","article-title":"Nose to brain targeted drug delivery bypassing the blood-brain barrier: an overview.","volume":"4","author":"Patel","year":"2012","journal-title":"Drug Invent. Today"},{"key":"10.1016\/j.ejmech.2020.112905_bib63","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in\u00a0vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2020.112905_bib64","first-page":"8","article-title":"Solid lipid nanoparticles-a review","volume":"5","author":"Yadav","year":"2013","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib65","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/10611860802476504","article-title":"Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting","volume":"16","author":"Kumar","year":"2008","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.ejmech.2020.112905_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/17425247.5.1.119","article-title":"Microemulsions as novel drug carriers: the formation, stability, applications and toxicity","volume":"5","author":"Karasulu","year":"2008","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2020.112905_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","article-title":"Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in\u00a0vivo anti-Parkinson activity","author":"Raj","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2020.112905_bib68","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41598-017-01279-1","article-title":"Sensitization of glioblastoma tumor micro-environment to chemo-and immunotherapy by Galectin-1 intranasal knock-down strategy","volume":"7","author":"Van Woensel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112905_bib69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/17425247.3.4.463","article-title":"The performance of nanocarriers for transmucosal drug delivery","author":"Csaba","year":"2006","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2020.112905_bib70","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in\u00a0vitro and in\u00a0vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejmech.2020.112905_bib71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2020.112905_bib72","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s13346-019-00702-6","article-title":"Exploring micellar-based polymeric systems for effective nose-to-brain drug delivery as potential neurotherapeutics","volume":"10","author":"Pokharkar","year":"2020","journal-title":"Drug Deliv. and Transl. Res."},{"key":"10.1016\/j.ejmech.2020.112905_bib73","first-page":"692","article-title":"Nanomedicine for Parkinson disease: current status and future perspective","volume":"4","author":"Jayaraj","year":"2013","journal-title":"Int. J. Pharm. Bio. Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib74","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2010.04.021","article-title":"Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats","volume":"393","author":"Dong","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib75","first-page":"3380","article-title":"Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer. Mol","volume":"12","author":"Katare","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2020.112905_bib76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phrs.2008.08.002","article-title":"Evaluation of age and sex differences in locomotion and catalepsy during repeated administration of haloperidol and clozapine in adolescent and adult rats","volume":"58","author":"Wiley","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2020.112905_bib77","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1021\/jp9021618","article-title":"New insights into the interactions between dendrimers and surfactants: 2. Design of new drug formulations based on dendrimer-surfactant aggregates","volume":"113","author":"Cheng","year":"2009","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2020.112905_bib78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/nano9020147","article-title":"An available strategy for nasal brain transport of nanocomposite based on PAMAM dendrimers via in situ gel","volume":"9","author":"Xie","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejmech.2020.112905_bib79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17425247.2013.746659","article-title":"Mucoadhesivein situnasal gelling drug delivery systems for modulated drug delivery","volume":"10","author":"Singh","year":"2012","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2020.112905_bib80","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ijpharm.2018.07.014","article-title":"A\u00a0novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gelformulation for brain targeting: preparation, characterization and in\u00a0vivo evaluation","volume":"548","author":"Youssef","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejpb.2017.10.008","article-title":"In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin","volume":"122","author":"Mura","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib82","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s10753-016-0426-z","article-title":"Paeonol suppresses neuroinflammatory responses in LPS-activated microglia cells","volume":"39","author":"He","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2020.112905_bib83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2007.06.057","article-title":"Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury","volume":"264","author":"Wu","year":"2008","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jchromb.2017.09.015","article-title":"Systematic characterization of the metabolites of paeonol in rats using ultra performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry with an integrative strategy","volume":"1065\u20131066","author":"Ding","year":"2017","journal-title":"J.\u00a0Chromatogr. Biomed. Appl."},{"key":"10.1016\/j.ejmech.2020.112905_bib85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10717540903447194","article-title":"In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in\u00a0vitro evaluation and in\u00a0vivo pharmacokinetic study in rabbits","volume":"17","author":"Mahajan","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejmech.2020.112905_bib86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.msec.2016.12.134","article-title":"Role of generation on folic acid-modified poly (amidoamine)dendrimers for targeted delivery of baicalin to cancer cells.","volume":"75","author":"Lv","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ejmech.2020.112905_bib87","doi-asserted-by":"crossref","unstructured":"Wang, H.; O Bloom; Zhang, O.; Vishnubhakat, J. M.; Ombrellino, M.; Che, J.; Frazier, A.; Yang, H.; Ivanova, S.; Borovikova, L.; Manogue, K. R.; Faist, E.; Abraham, E.; Andersson, J.; Andersson, U.; Molina, P. E.; Abumrad, N. N.; Sama, A.; Tracey, K. J., HMG-1 as a late mediator of endotoxin lethality in mice. Science 199, 285, 248\u2013251.","DOI":"10.1126\/science.285.5425.248"},{"key":"10.1016\/j.ejmech.2020.112905_bib88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916939409009542","article-title":"Nerve growth factor andautoimmune diseases","volume":"19","author":"Aloe","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejmech.2020.112905_bib89","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.carbpol.2011.01.057","article-title":"\u03b2-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery","volume":"84","author":"Zhang","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2020.112905_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2020.112905_bib91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2018.10.029","article-title":"Advanced formulations for intranasal delivery of biologics","volume":"553","author":"Rohrer","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib92","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2012.09.017","article-title":"Approaches for breaking the barriers of drug permeation through transdermal drug delivery","volume":"164","author":"Alexander","year":"2012","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2020.112905_bib93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2017.11.007","article-title":"Bench-to-bedside translation of dendrimers: reality or utopia? A concise analysis","volume":"136\u2013137","author":"Mignani","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2020.112905_bib94","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/biom10040642","article-title":"The role of branch cell symmetry and other critical nanoscale design parameters in the determination of dendrimer encapsulation properties","volume":"10","author":"Tomalia","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib95","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/acs.bioconjchem.0c00395","article-title":"Dendrimers toward translational nanotherapeutics: concise key step analysis","volume":"31","author":"Mignani","year":"2020","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2020.112905_bib96","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.progpolymsci.2013.03.003","article-title":"Dendrimer space concept for innovative nanomedicine: a futuristic vision for medicinal chemistry","volume":"38","author":"Mignani","year":"2013","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejmech.2020.112905_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bm501285t","article-title":"Advances in combination t herapies based on nanoparticles for efficacious cancer treatment: an analytical report","volume":"16","author":"Mignani","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2020.112905_bib98","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/C7CS00550D","article-title":"Dendrimers in combination with natural products and analogues as anti-cancer agents","volume":"47","author":"Mignani","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2020.112905_bib99","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/ph6020161","article-title":"Dendrimers for siRNA delivery","volume":"6","author":"Biswas","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2020.112905_bib100","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1039\/D0TB00346H","article-title":"Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core\u2013shell tecto dendrimers formed via supramolecular host\u2013guest assembly","volume":"8","author":"Song","year":"2020","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.ejmech.2020.112905_bib101","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1021\/acs.bioconjchem.9b00385","article-title":"Dendrimer-enabled therapeutic antisense delivery systems as innovation in medicine","volume":"30","author":"Mignani","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2020.112905_bib102","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.drudis.2020.03.009","article-title":"Dendrimer\u2013 and polymeric nanoparticle\u2013aptamer bioconjugates as nonviral delivery systems: a new aapproach in medicine","volume":"25","author":"Mignani","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112905_bib103","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/acs.molpharmaceut.7b00771","article-title":"Original multivalent gold(III) and dual gold(III)\u2212copper(II) conjugated phosphorus dendrimers as potent antitumoral and antimicrobial agents","volume":"14","author":"Mignani","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2020.112905_bib104","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.drudis.2020.06.018","article-title":"Current and future therapeutical approaches for COVID-19","volume":"25","author":"Duan","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112905_bib105","author":"Wilson"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:25:52Z","timestamp":1759328752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420308771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":104,"alternative-id":["S0223523420308771"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112905","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112905"}}